9th Circ. To Review Class Certification In Diabetes Drug Suit

By Mike Curley · August 23, 2023, 7:46 PM EDT

The Ninth Circuit on Wednesday agreed to review a grant of class certification in a suit by third-party payors alleging that Takeda Pharmaceutical Co. and Eli Lilly & Co. hid risks...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Painters and Allied Trades District Council 82 Health Care Fund et al v. Takeda Pharmaceutical Co Ltd et al

Case Number

2:17-cv-07223

Court

California Central

Nature of Suit

Racketeer/Corrupt Organization

Date Filed

September 29, 2017